De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia

Publication date

2020-02-01

Authors

GROUP Investigators

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Schizophrenia is a highly polygenic disorder with important contributions from both common and rare risk alleles. We analyzed exome sequencing data for de novo variants (DNVs) in a new sample of 613 schizophrenia trios and combined this with published data to give a total of 3,444 trios. In this new data, loss-of-function (LoF) DNVs were significantly enriched among 3,471 LoF-intolerant genes, which supports previous findings. In the full dataset, genes associated with neurodevelopmental disorders (n = 159) were significantly enriched for LoF DNVs. Within these neurodevelopmental disorder genes, SLC6A1, which encodes a γ-aminobutyric acid transporter, was associated with missense-damaging DNVs. In 1,122 trios for which genome-wide common variant data were available, schizophrenia and bipolar disorder polygenic risk were significantly overtransmitted to probands. Probands carrying LoF or deletion DNVs in LoF-intolerant or neurodevelopmental disorder genes had significantly less overtransmission of schizophrenia polygenic risk than did non-carriers, which provides a second robust line of evidence that these DNVs increase liability to schizophrenia.

Keywords

Adult, Female, GABA Plasma Membrane Transport Proteins/genetics, Genetic Predisposition to Disease/genetics, Humans, Male, Mutation, Missense, Schizophrenia/genetics, Whole Exome Sequencing, Taverne, General Neuroscience, Research Support, Non-U.S. Gov't, Journal Article

Citation

GROUP Investigators 2020, 'De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia', Nature Neuroscience, vol. 23, no. 2, pp. 179-184. https://doi.org/10.1038/s41593-019-0565-2